Gurrola Sandra M
SEC CIK 1618457 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | VP of Fin | 110 | — | — | 7 | 2022-06-21 | 2025-06-21 |
Most active insiders at ERNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Cherington Charles | 10% | $2.00M | — |
Gurrola Sandra M made no open-market trades at ERNA in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-07 | 2025-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | SVP of Fin | M - OptEx | — | +30 | 110 | +38% | — |
| D | 2024-06-25 | 2024-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | SVP of Fin | M - OptEx | — | +437 | 1,365 | +47% | — |
| D | 2024-06-25 | 2024-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | SVP of Fin | F - Tax | $1.94 | -180 | 1,185 | -13% | -$349.20 |
| D | 2023-06-23 | 2023-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | VP of Fin | F - Tax | $2.48 | -179 | 928 | -16% | -$443.92 |
| D | 2023-06-23 | 2023-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | VP of Fin | M - OptEx | — | +438 | 1,107 | +65% | — |
| D | 2022-06-23 | 2022-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | VP of Fin | M - OptEx | — | +8,750 | 17.0K | +107% | — |
| D | 2022-06-23 | 2022-06-21 | ERNA | Ernexa Therapeutics Inc. | Gurrola Sandra M | VP of Fin | F - Tax | $0.48 | -3,586 | 13.4K | -21% | -$1,721 |
Purchase Sale Sale after option exercise All abbreviations